Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III double-blind randomized placebo-controlled idebenone trial in Duchenne muscular dystrophy (10–18 years)
2009-012037-30Phase 3Completed
- Sponsor
- Santhera Pharmaceuticals
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Duchenne muscular dystrophy (DMD) comparing Idebenone with Placebo (2 arms). Primary endpoint: Change in percent predicted Peak Expiratory Flow (PEF). Started May 2009; status: completed.
02
Drugs
idebenone
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on 2009-012037-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012037-30.